Millennium Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.2K Sell
43,059
-1,249,714
-97% -$1.17M ﹤0.01% 5474
2025
Q4
$2M Buy
1,292,773
+1,183,461
+1,083% +$1.89M ﹤0.01% 3953
2025
Q3
$173K Sell
109,312
-53,838
-33% -$93.6K ﹤0.01% 5585
2025
Q2
$356K Sell
163,150
-1,215,179
-88% -$2.94M ﹤0.01% 5105
2025
Q1
$3.76M Sell
1,378,329
-1,362,542
-50% -$5.37M ﹤0.01% 3143
2024
Q4
$11.4M Sell
2,740,871
-1,451,994
-35% -$5.49M 0.01% 2061
2024
Q3
$16.3M Sell
4,192,865
-985,088
-19% -$4.15M 0.01% 1736
2024
Q2
$20.3M Sell
5,177,953
-993,093
-16% -$4.27M 0.01% 1489
2024
Q1
$25.9M Buy
6,171,046
+1,158,763
+23% +$5.44M 0.01% 1329
2023
Q4
$23.6M Buy
5,012,283
+1,165,642
+30% +$4.54M 0.01% 1406
2023
Q3
$12M Buy
3,846,641
+1,909,649
+99% +$7.68M 0.01% 1881
2023
Q2
$8.89M Sell
1,936,992
-910,161
-32% -$4.18M ﹤0.01% 2134
2023
Q1
$14.1M Buy
2,847,153
+948,640
+50% +$4.67M 0.01% 1639
2022
Q4
$10.4M Buy
1,898,513
+474,178
+33% +$2.91M 0.01% 2086
2022
Q3
$9.26M Sell
1,424,335
-930,751
-40% -$5.19M 0.01% 2248
2022
Q2
$11.1M Buy
2,355,086
+947,104
+67% +$4.66M 0.01% 1919
2022
Q1
$9.84M Buy
+1,407,982
New +$9.61M 0.01% 2189
2021
Q4
Sell
-422,442
Closed -$5.16M 7172
2021
Q3
$5.16M Buy
+422,442
New +$6.37M ﹤0.01% 2826

Other funds holding MXCT

Millennium Management's MXCT Position: Q1 2026 in Review

Millennium Management reduced its MaxCyte (MXCT) stake by 97% in Q1 2026, selling an estimated $1.17M and leaving 43,059 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5474.

Millennium Management first reported a position in MXCT in Q3 2021 and has held it in 18 quarters since. The position peaked at $25.9M in Q1 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Millennium Management held 43,059 shares of MaxCyte worth $30.2K as of Q1 2026.
  • Millennium Management sold 1,249,714 MaxCyte shares in Q1 2026, an estimated $1.17M.
  • MaxCyte made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5474 holding.
  • Millennium Management first reported a position in MaxCyte in Q3 2021 and has held it in 18 quarters since.
  • Millennium Management's MaxCyte position peaked at $25.9M in Q1 2024.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.